Test Price
120 AEDโ Home Collection Available
NAFLD Fibrosis Score Test in UAE โ Non-Invasive Liver Fibrosis Risk Assessment
Executive Summary & Core Metrics
The NAFLD Fibrosis Score Test delivers a reliable, non-invasive estimate of liver fibrosis severity using routine blood parameters and clinical data. This validated algorithm stratifies risk without the need for tissue biopsy, enabling early intervention and monitoring. At 120 AED with a 24-hour turnaround, it offers an accessible, high-value screening pathway for individuals with fatty liver concerns.
Core Metrics
Price: 120 AED | Turnaround: Results within 24 hours | Sample: Simple blood draw via VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily 8 AMโ11 PM) | Methodology: Standardised blood chemistry (IFCC, BCG, Electrical Impedance) with algorithmic scoring | DHA Licensed Facility: License No. 1143, Dubai Healthcare City
Test Overview & Methodology
The NAFLD Fibrosis Score is a non-invasive, blood-based algorithm that calculates liver fibrosis probability using age, body mass index, platelet count, albumin, and diabetes status. By integrating standard clinical chemistry and haematology results, the test effectively stratifies patients into low, indeterminate, or high risk for advanced fibrosis, reducing reliance on invasive biopsy. Our DHA-licensed laboratory processes samples daily under ISO 9001:2015 standards, ensuring consistent accuracy and traceability.
| Feature | Our NAFLD Fibrosis Score Test | Liver Biopsy (Alternative) |
|---|---|---|
| Precision / Method | Standardised blood chemistry (IFCC, BCG, Electrical Impedance) with validated scoring algorithm | Histopathological analysis of invasive tissue sample |
| Speed & TAT | Results within 24 hours (daily processing) | 5โ7 days dependent on pathology lab |
| Patient Experience | Simple blood draw; VIP mobile phlebotomy home collection available; no hospital stay required | Outpatient procedure with local anaesthesia; risk of bleeding and post-procedural pain |
| Regulatory Compliance | DHA / MOHAP standard nomenclature; ISO 9001:2015 accredited laboratory | Requires accredited surgical facility and pathologist |
Physician Insight & Safety Protocols
Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132), advises: โThe NAFLD Fibrosis Score serves as a practical first-line screening tool for clinically significant liver fibrosis. When interpreted alongside a complete history and physical examination, it helps determine which patients may benefit from further imaging or specialist referral. An elevated score should prompt a structured hepatology evaluation, while a low score offers reassurance. Our team provides telephonic guidance with every result to support informed decision-making and address any concerns.โ
Clinical Advisory: Interpreting the Score
This test is a risk stratification tool, not a standalone diagnostic confirmation. An indeterminate or high score requires correlation with abdominal imaging (e.g., transient elastography, ultrasound) and, if indicated, liver biopsy. Patients with known chronic liver disease should continue all prescribed treatments and follow-up schedules as directed by their hepatologist.
Exclusion Criteria & Emergency Red Flags
- Acute hepatic decompensation or clinical evidence of acute hepatitis.
- Pregnancy or breastfeeding without prior clinical correlation.
- Uncontrolled diabetes or active systemic infection that may confound laboratory parameters.
Seek immediate medical attention if you experience: severe right upper quadrant pain, new-onset jaundice, confusion or altered mental status, haematemesis, or melaena (black tarry stools).
Patient FAQ & Clinical Guidance
1. What is the NAFLD Fibrosis Score test and how is it performed?
This test uses a single blood sample alongside your age, BMI, and diabetes status to calculate a validated fibrosis risk score. The sample is analysed using IFCC, BCG, and electrical impedance methods in our DHA-licensed laboratory, and a report is issued within 24 hours. The scoring algorithm classifies your likelihood of advanced liver fibrosis as low, indeterminate, or high, enabling targeted clinical follow-up.
2. How should I prepare for the NAFLD Fibrosis Score?
You must fast for 8โ12 hours before blood collection, though plain water is permitted. Please provide your accurate height, weight, age, and known diabetes status. Continue all prescribed medications unless your doctor specifically advises otherwise. Our VIP home collection team will capture all mandatory details on arrival and ensure proper sample handling under cold-chain protocol.
3. What do abnormal NAFLD Fibrosis Score results mean?
A high score correlates with a greater probability of advanced liver fibrosis, but it is not a definitive diagnosis. Results in the indeterminate or high range warrant further evaluation by a hepatologist, including imaging studies such as elastography or ultrasound. Our telephonic clinical guidance service will help you interpret your score and outline appropriate next steps.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
All patient data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed under Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds a valid DHA facility license (No. 1143) and ISO 9001:2015 certification, ensuring rigorous quality management and data security throughout the testing lifecycle.
Clinical & Logistical Metadata
| Test Name | NAFLD Fibrosis Score |
| Price (AED) | 120 AED |
| Turnaround Time | Results within 24 hours (daily processing) |
| Sample Type / Matrix | Peripheral whole blood (serum/plasma) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AMโ11 PM |
| Methodology Used | IFCC (enzymatic), BCG (colorimetric), Electrical Impedance (haematology) โ algorithmic scoring |
| ICD-10-CM Code | K76.0 (Fatty liver, not elsewhere classified) |
| LOINC Code | 76470-5 (NAFLD fibrosis score) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians